Please assess the completion status of the following clinical trial:

Trial Title: Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria: pancreatic solid lesion presence (pancreatic adenocarcinoma and neuroendocrine tumors) resected during pancreatic surgery -~Exclusion Criteria: no signature on informed consent~-

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- resected PDAC without neoadjuvant chemotherapy treatment (Type: EXPERIMENTAL): Subgroup A: 10 W (5 patients) Subgroup B: 30 W (5 patients) Subgroup C: 50 W (5 patients)
- resected PDAC with neoadjuvant chemotherapy treatment (Type: EXPERIMENTAL): Subgroup A: 10 W (5 patients) Subgroup B: 30 W (5 patients) Subgroup C: 50 W (5 patients)
- resected neuroendocrine tumors (Type: EXPERIMENTAL): Subgroup A: 10 W (5 patients) Subgroup B: 30 W (5 patients) Subgroup C: 50 W (5 patients)

Based on this trial design, predict the completion outcome and termination type (if applicable).